Marex Group plc (MRX), the diversified global financial services platform, today announces the pricing of its initial public offering (the “IPO”), at $19 per share. The offering includes a total of 15,384,615 shares of common stock, of which 3,846,153 shares are offered by Marex and 11,538,462 shares are offered by certain selling shareholders (the “Selling Shareholders”). Marex will not receive any proceeds from the sale of shares by the Selling Shareholders. The common stock is expected to begin trading on the Nasdaq Global Select Market on April 25, 2024, under the symbol “MRX.” The offering is expected to close on April 29, 2024, subject to standard closing conditions.
In connection with the offering, the Selling Shareholders have granted the underwriters a 30-day option to purchase an additional 2,307,692 shares of common stock to address potential excess demand.
Barclays, Goldman Sachs & Co. LLC, Jefferies and Keefe, Bruyette & Woods, a Stifel company, act as joint lead book-running managers and representatives of the underwriters for the proposed offering. Citigroup, UBS Investment Bank, Piper Sandler and HSBC are the bookrunners for the proposed offering. Drexel Hamilton and Loop Capital Markets are co-managing the proposed offering.
The proposed offering is being conducted solely by means of a prospectus. Copies of the prospectus relating to the proposed offering can be requested from:
- Barclays Capital Inc., at Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847 or by email [email protected];
- Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone: 1-866-471-2526, or by email: [email protected];
- Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388 or by email [email protected]; or
- Keefe, Bruyette & Woods Inc., 787 Seventh Avenue, Fourth Floor, New York, NY 10019, Attention: Equity Capital Markets, or by calling toll-free at (800) 966-1559 or by email at [email protected].
Third Party Advertisement. This is not an offer or recommendation by Investing.com. Consult the information here or
remove ads
.
A registration statement for these securities has been filed with and declared effective by the U.S. Securities and Exchange Commission. This press release is not an offer to sell or a solicitation to buy any securities and is not a solicitation of any offer, solicitation or sale in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or compliance with the laws on the securities of that jurisdiction.
This article was created and translated with the assistance of AI and reviewed by an editor. For more information, please see our Terms and Conditions.
